Buckysomes: Fullerene-based nanocarriers for hydrophobic molecule delivery

ACS Nano

Volumn 2, Issue 9, 2008, Pages 1950-1958

  Partha, Ranga ^a   Mitchell, Linsey R ^a   Lyon, Jennifer L ^a   Joshi, Pratixa P ^a   Conyers, Jodie L ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

AF 1; Amphiphilic fullerene; Bucksome; Drug delivery; Paclitaxel; Self assembly

Indexed keywords

CELL GROWTH; DRUG DELIVERY; FULLERENES; GROWTH KINETICS; MICROSCOPIC EXAMINATION; MOLECULES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; SELF ASSEMBLY; SPHERES;

AF-1; AMPHIPHILIC; AMPHIPHILIC FULLERENE; BOUND FORMULATIONS; BREAST CANCER CELLS; BUCKSOME; CELLULAR INTERNALIZATIONS; CYTOTOXIC; DYNAMIC LIGHT; ELEVATED TEMPERATURES; EMBEDDING; FLUORESCENT DYES; HYDROPHOBIC; HYDROPHOBIC ANTICANCER DRUGS; HYDROPHOBIC MOLECULES; HYDROPHOBIC REGIONS; IN CELLS; IN VITRO; IN VITRO STUDIES; NANOCARRIERS; NANOMATERIALS; NEGATIVE CONTROLS; PACLITAXEL;

HYDROPHOBICITY;

DRUG CARRIER; FULLERENE DERIVATIVE; NANOMATERIAL; PACLITAXEL;

ARTICLE; BREAST TUMOR; CHEMISTRY; HUMAN; HYDROPHOBICITY; PATHOLOGY; TUMOR CELL LINE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG CARRIERS; FULLERENES; HUMANS; HYDROPHOBICITY; NANOSTRUCTURES; PACLITAXEL;

EID: 54249096987     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn800422k     Document Type: Article

References (59)

1. Ferrari, M. Cancer Nanotechnology: Opportunities and Challenges. Nat. Rev. Cancer 2005, 5, 161-171.
2. Storm, G.; Crommelin, D. J. A. Liposomes: Quo Vadis. Pharm. Sci. Technol. Today 1998, 1, 19-31.
3. Kao, C.-Y.; Hoffman, E. A.; Beck, K. C.; Bellamkonda, R. V.; Annapragada, A. V. Long-Residence-Time Nano-Scale Liposomal lohexol for X-Ray-Based Blood Pool Imaging. Acad. Radiol. 2003, 10, 475-483.
4. Mukundan, S., Jr.; Ghaghada, K. B.; Badea, C. T.; Kao, C.-Y.; Hedlund, L. W.; Provenzale, J. M.; Johnson, G. A.; Chen, E.; Bellamkonda, R. V.; Annapragada, A. A Liposomal Nanoscale Contrast Agent for Preclinical CT in Mice. Am. J. Roentgenol. 2006, 186, 300-307.
5. Lasic, D. D.; Papahadjopoulos, D. Liposomes Revisited. Science 1995, 267, 1275-1276.
6. Thanyani, S. T.; Roberts, V.; Siko, D. G. R.; Vrey, P.; Verschoor, J. A. A Novel Application of Affinity Biosensor Technology to Detect Antibodies to Mycolic Acid in Tuberculosis Patients. J. Immunol. Methods 2008, 332, 61-72.
7. Torchilin, V. P. Multifunctional Nanocarriers. Adv. Drug Delivery Rev. 2006, 58, 1532-1555.
8. Dhanikula, A. B.; Panchagnula, R. Preparation and Characterization of Water-Soluble Prodrug, Liposomes and Micelles of Paclitaxel. Curr. Drug Delivery 2005, 2, 75-91.
9. Yang, T.; Choi, M.-K.; Cui, F.-D.; Kim, J. S.; Chung, S.-J.; Shim, C.-K.; Kim, D.-D. Preparation and Evaluation of Paclitaxel-Loaded PEGylated Immunoliposome, J. Controlled Release 2007, 120, 169-177.
10. Yang, T.; Cui, F.-D.; Choi, M.-K.; Cho, J.-W.; Chung, S.-J.; Shim, C.-K.; Kim, D.-D. Enhanced Solubility and Stability of PEGylated Liposomal Paclitaxel: In vitro and in vivo Evaluation. Int. J. Pharm. 2007, 338, 317-326.
11. Yang, T.; Choi, M.-K.; Cui, F.-D.; Lee, S.-J.; Chung, S.-J.; Shim, C.-K.; Kim, D.-D. Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells. Pharm. Res. 2007, 24, 2402-2411.
12. Yang, T.; Cui, F.-D.; Choi, M.-K.; Lin, H.; Chung, S.-J.; Shim, C.-K.; Kim, D.-D. Liposome Formulation of Paclitaxel with Enhanced Solubility and Stability. Drug Delivery 2007, 14, 301-308.
13. Peltier, S.; Oger, J.-M.; Lagarce, F.; Couet, W.; Benoit, J.-P. Enhanced Oral Paclitaxel Bioavailability After Administration of Paclitaxel-Loaded Lipid Nanocapsules. Pharm. Res. 2006, 23, 1243-1250.
14. 60) Induce Oxidative Stress in the Brain of Juvenile Largemouth Bass. Environ. Health Perspect. 2004, 112, 1058-1062.
15. Zhu, S.; Oberdorster, E.; Haasch, M. L. Toxicity of an Engineered Nanoparticle (Fullerene, C60) in Two Aquatic Species, Daphnia and Fathead Minnow. Mar. Environ. Res. 2006, 62 (Suppl.), S5-9.
16. Gharbi, N.; Pressac, M.; Hadchouel, M.; Szwarc, H.; Wilson, S. R.; Moussa, F. [60]Fullerene is a Powerful Antioxidant in vivo with No Acute or Subacute Toxicity. Nano Lett. 2005, 5, 2578-2585.
17. Zhou, S.; Burger, C.; Chu, B.; Sawamura, M.; Nagahama, N.; Toganoh, M.; Hackler, U. E.; Isobe, H.; Nakamura, E. Spherical Bilayer Vesicles of Fullerene-Based Surfactants in Water: A Laser Light Scattering Study. Science 2001, 291, 1944-1947.
18. Georgakilas, V.; Pellarini, F.; Prato, M.; Guldi, D. M.; Melle-Franco, M.; Zerbetto, F. Supramolecular Self-Assembled Fullerene Nanostructures. Proc. Natl. Acad Sci. U.S.A. 2002, 99, 5075-5080.
19. Liu, Y.; Xiao, S.; Li, H.; Li, Y.; Liu, H.; Lu, F.; Zhuang, J.; Zhu, D. Self-Assembly and Characterization of A Novel Hydrogen-Bonded Nanostructure. J. Phys. Chem. B 2004, 108, 6256-6260.
20. Guldi, D. M.; Zerbetto, F.; Georgakilas, V.; Prato, M. Ordering Fullerene Materials at Nanometer Dimensions. Acc. Chem. Res. 2005, 38, 38-43.
21. Brettreich, M.; Hirsch, A. A Highly Water-Soluble Dendro[60]fullerene. Tetrahedron Lett. 1998, 39, 2731-2734.
22. 60-Fullerenes: A Film Balance, Neutron-, and Infrared Reflection Study. Langmuir 2000, 16, 8884-8891.
23. 60. Angew. Chem., Int. Ed. 2000, 39, 1845-1848.
24. Braun, M.; Atalick, S.; Guldi, D. M.; Lanig, H.; Brettreich, M.; Burghardt, S.; Hatzimarinaki, M.; Ravanelli, E.; Prato, M.; van Elclik, R.; et al. Electrostatic Complexation and Photoinduced Electron Transfer between Zn-Cytochrome c and Polyanionic Fullerene Dendrimers. Chem.-Eur. J. 2003, 9, 3867-3875.
25. Burghardt, S.; Hirsch, A.; Schade, B.; Ludwig, K.; Boettcher, C. Switchable Supramolecular Organization of Structurally Defined Micelles based on an Amphiphilic Fullerene. Angew. Chem, Int. Ed. 2005, 44, 2976-2979.
26. 60 Fullerene Derivatives into Nanoscale Supramolecular Structures. J. Nanobiotechnol. 2007, 5, 1-11.
27. Rowinsky, E. K.; Donehower, R. C. Paclitaxel (Taxol). New Engl. J. Med. 1995, 332, 1004-1014.
28. Mekhail, T. M.; Markman, M. Paclitaxel in Cancer Therapy. Expert Opin. Pharmacother. 2002, 3, 755-766.
29. Crosasso, P.; Ceruti, M.; Brusa, P.; Arpicco, S.; Dosio, F.; Cattel, L. Preparation, Characterization and Properties of Sterically Stabilized Paclitaxel-Containing Liposomes. J. Controlled Release 2000, 63, 19-30.
30. Sharma, A.; Sharma, U. S.; Straubinger, R. M. Paclitaxel-Liposomes for Intracavitary Therapy of Intraperitoneal P388 Leukemia. Cancer Lett. 1996, 107, 265-272.
31. Singla, A. K.; Garg, A.; Aggarwal, D. Paclitaxel and its Formulations. Int. J. Pharm. 2002, 235, 179-192.
32. Gelderblom, H.; Verweij, J.; Nooter, K.; Sparreboom, A. Cremophor EL: The Drawbacks and Advantages of Vehicle Selection for Drug Formulation. Eur. J. Cancer 2001, 37, 1590-1598.
33. Schnycler, A.; Huwyler, J. Drug Transport to Brain with Targeted Liposomes. NeuroRX 2005, 2, 99-107.
34. Dubochet, J.; Adrian, M.; Chang, J. J.; Homo, J. C.; Lepault, J.; McDowall, A. W.; Schultz, P. Cryo-Electron Microscopy of Vitrified Specimens. Q. Rev. Biophys. 1988, 21, 129-228.
35. Lasic, D. D.; Frederik, P. M.; Stuart, M. C. A.; Barenholz, Y.; McIntosh, T. J. Gelation of Liposome Interior. A Novel Method for Drug Encapsulation. FEBS Lett. 1992, 312, 255-258.
36. Frederik, P. M.; Hubert, D. H. W. Cryoelectron Microscopy of Liposomes. Methods Enzymol. 2005, 391, 431-448.
37. Sulkowski, W. W.; Pentak, D.; Nowak, K.; Sulkowska, A. The Influence of Temperature and pH on the Structure of Liposomes Formed from DMPC. J. Mol. Struct. 2006, 792-793, 257-264.
38. Ellens, H.; Bentz, J.; Szoka, F. C. Destabilization of Phosphatidylethanolamine Liposomes at the Hexagonal Phase Transition Temperature. Biochemistry 1986, 25, 285-294.
39. Israelachvili, J. N.; Mitchell, D. J.; Ninham, B. W. Theory of Self-Assembly of Lipid Bilayers and Vesicles. Biochim. Biophys. Acta 1977, 470, 185-201.
40. Gulik-Krzywicki, T.; Dedieu, J. C.; Roux, D.; Degert, C.; Laversanne, R. Freeze-Fracture Electron Microscopy of Sheared Lamellar Phase. Langmuir 1996, 12, 4668-4671.
41. Hoppe, W.; Hegerl, R. Three-Dimensional Structure Determination by Electron Microscopy (Non-Periodic Specimens). In Computer Processing of Electron Microscope Images, Hawkes, P. W., Ed.; Springer-Verlag: Berlin, 1980; pp 127-185.
42. Jiang, Q.-X.; Chester, D. W.; Sigworth, F. J. Spherical Reconstruction: A Method for Structure Determination of Membrane Proteins from Cryo-EM Images. J. Struct. Biol. 2001, 133, 119-131.
43. Lucic, V.; Leis, A.; Baumeister, W. Cryo-Electron Tomography of Cells: Connecting Structure and Function. Histochem Cell Biol. 2008, 130, 185-196.
44. Hirai, M.; Iwase, H.; Hayakawa, T.; Koizumi, M.; Takahashi, H. Determination of Asymmetric Structure of Ganglioside-DPPC Mixed Vesicle using SANS, SAXS, and DLS. Biophys. J. 2003, 85, 1600-1610.
45. Park, S.-H.; Oh, S.-G.; Mun, J.-Y.; Han, S.-S. Loading of Gold Nanoparticles Inside the DPPC Bilayers of Liposome and Their Effects on Membrane Fluidities. Colloids Surf. B 2006, 48, 112-118.
46. Jordan, M. A.; Wilson, L. Microtubules as a Target for Anticancer Drugs. Nat. Rev. Cancer 2004, 4, 253-265.
47. Desai, N. P.; Louie, L.; Ron, N.; Magdassi, S.; Soon-Shiong, P. Protein-Based Nanoparticles for Drug Delivery of Paclitaxel. Transactions of the Sixth World Biomaterials Congress; Society for Biomaterials: Mt. Laurel, NJ, 2000; Vol. 1, p 199.
48. Ibrahim, N. K.; Desai, N.; Legha, S.; Soon-Shiong, P.; Theriault, R. L.; Rivera, E.; Esmaeli, B.; Ring, S. E.; Bedikian, A.; Hortobagyi, G. N.; et al. Phase I and Pharmacokinetic Study of ABI-007, a Cremophor-Free, Protein-Stabilized, Nanoparticle Formulation of Paclitaxel. Clin. Cancer Res. 2002, 8, 1038-1044.
49. Huang, L.; Connor, J.; Wang, C. Y. pH-Sensitive Immunoliposomes. Methods Enzymol. 1987, 149, 88-99.
50. Mastrobattista, E.; Koning, G. A.; Storm, G. Immunoliposomes for the Targeted Delivery of Antitumor Drugs. Adv. Drug Delivery Rev. 1999, 40, 103-127.
51. Kirpotin, D.; Park, J. W.; Hong, K.; Zalipsky, S.; Li, W.-L.; Carter, P.; Benz, C. C.; Papahadjopoulos, D. Sterically Stabilized Anti-HER2 Immunoliposomes: Design and Targeting to Human Breast Cancer Cells in vitro. Biochemistry 1997, 36, 66-75.
52. Miller, C. R.; Bondurant, B.; McLean, S. D.; McGovern, K. A.; O'Brien, D. F. Liposome-Cell Interactions in Vitro: Effect of Liposome Surface Charge on the Binding and Endocytosis of Conventional and Sterically Stabilized Liposomes. Biochemistry 1998, 37, 12875-12883.
53. Siwak, D. R.; Tari, A. M.; Lopez-Berestein, G. The Potential of Drug-Carrying Immunoliposomes as Anticancer Agents. Clin. Cancer Res. 2002, 8, 955-956.
54. Greish, K. Enhanced Permeability and Retention of Macromolecular Drugs in Solid Tumors: A Royal Gate for Targeted Anticancer Nanomedicines. J. Drug Target. 2007, 15, 457-464.
55. Adis Data Information, B. V. ABI 007. Adis R&D Profile. Drugs R&D 2004, 5, 155-159.
56. Scripture, C. D.; Figg, W. D.; Sparreboom, A. Paclitaxel Chemotherapy: From Empiricism to a Mechanism-Based Formulation Strategy. Ther. Clin. Risk Manage. 2005, 1, 107-114.
57. Gradishar, W. J. Albumin-Bound Paclitaxel: A Next-Generation Taxane. Expert Opin. Pharmacother. 2006, 7, 1041-1053.
58. Hawkins, M. J.; Soon-Shiong, P.; Desai, N. Protein Nanoparticles as Drug Carriers in Clinical Medicine. Adv. Drug Delivery Rev. 2008, 60, 876-885.
59. Russo, J.; Soule, H. D.; McGrath, C.; Rich, M. A. Reexpression of the Original Tumor Pattern by a Human Breast Carcinoma Cell Line (MCF-7) in Sponge Culture. J. Natl. Cancer. Inst. 1976, 56, 279-282.